Statement Of Financial Position [Abstract]

Egetis Therapeutics - Filing #690710

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Right-of-use assets	26,000,000 SEK	—	—	—	—	41,000,000 SEK	—	—	—	—	—	—	—	—	—
Other non-current financial assets	8,000,000 SEK	—	—	—	—	8,000,000 SEK	—	—	—	—	—	—	—	—	—
Non-current assets	4,137,000,000 SEK	—	—	—	—	4,164,000,000 SEK	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Current inventories	6,000,000 SEK	—	—	—	—	7,000,000 SEK	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	1,277,000,000 SEK	—	—	—	—	1,440,000,000 SEK	—	—	—	—	2,879,000,000 SEK	—	—	—	—
Current assets	1,474,000,000 SEK	—	—	—	—	1,529,000,000 SEK	—	—	—	—	—	—	—	—	—
Assets	5,611,000,000 SEK	—	—	—	—	5,693,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	113,000,000 SEK	—	—	—	—	87,000,000 SEK	—	—	—	—	—	—	—	—	—
Retained earnings	9,396,000,000 SEK	—	—	—	—	7,458,000,000 SEK	—	—	—	—	—	—	—	—	—
Other reserves	61,000,000 SEK	—	—	—	—	13,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity	5,062,000,000 SEK	9,396,000,000 SEK	113,000,000 SEK	61,000,000 SEK	1 428,4 SEK	5,270,000,000 SEK	7,458,000,000 SEK	13,000,000 SEK	12,628,000,000 SEK	87,000,000 SEK	6,307,000,000 SEK	87,000,000 SEK	6,412,000,000 SEK	4,000,000 SEK	1 262,8 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities	55,000,000 SEK	—	—	—	—	31,000,000 SEK	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current liabilities	494,000,000 SEK	—	—	—	—	392,000,000 SEK	—	—	—	—	—	—	—	—	—
Equity and liabilities	5,611,000,000 SEK	—	—	—	—	5,693,000,000 SEK	—	—	—	—	—	—	—	—	—